NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:SRPT). Investors who purchased Sarepta securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SRPT.

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bakkt Holdings, Inc. ("Bakkt" or "the Company") (NYSE:BKKT). Investors who purchased Bakkt securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BKKT.

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BigBear.ai Holdings, Inc. ("BigBear" or "the Company") (NYSE:BBAI). Investors who purchased BigBear securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BBAI.

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. ("RLX" or "the Company") (NYSE:RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RLX.

NEW YORK CITY, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hesai Group ("Hesai" or "the Company") (NASDAQ: HSAI). Investors who purchased Hesai securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HSAI.

NEW YORK CITY, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XP Inc. ("XP" or "the Company") (NASDAQ:XP). Investors who purchased XP securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XP.

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the "Class Period").

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

The health and fitness boom is fueling demand for gyms, nutrition, and wellness services. Stocks like LTH, WW, SFM, and BYND are well-positioned to benefit.

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=138254&wire=1 or contact Joseph E. Levi, Esq.

The S&P 500 rose a half percent over its previous week's close, ending the third trading week of February 2025 at 5,667.56. We traced the potential end of the previous market regime to Friday, 21 February 2025, with a new regime then starting from Monday 24 February 2025.

The ever-volatile stock market bounced Monday as investors once again tilted toward the notion President Donald Trump's tariffs won't be quite as bad as first thought, with the latest rally led by the big technology stocks worst hit by the tariff-related market pullback.

Jim Cramer has, quite unexpectedly, referred to Nvidia stock (NASDAQ: NVDA) as a ‘shortsellers paradise'. Has the eccentric Mad Money host finally turned bearish on the chipmaker?

I love that Stride, Inc. is consistently generating strong free cash flow while still growing at a healthy pace. With a net cash position covering 6% of its market cap, the balance sheet is rock solid. Paying just 15x forward free cash flow for a company with mid-teen growth rates is a no-brainer.

Hold NVIDIA Corp. (NVDA) for the long term as the company's strong execution of the last several quarters and robust future projections will generate more value.

High funding costs, tariff-related uncertainty and poor asset quality will hurt the Zacks Major Regional Banks. Yet, interest rate cuts, decent loan demand and business restructuring will likely aid industry players like USB, BK, TFC & NTRS.

ViaSat (VSAT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

KT Corp. (KT) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.